Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arovella Therapeutics Ltd
Total Liabilities & Equity Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Total Liabilities & Equity
AU$13.3m
CAGR 3-Years
8%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Total Liabilities & Equity
AU$1.1B
CAGR 3-Years
-8%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Total Liabilities & Equity
AU$228.2m
CAGR 3-Years
129%
CAGR 5-Years
66%
CAGR 10-Years
25%
Botanix Pharmaceuticals Ltd
ASX:BOT
Total Liabilities & Equity
AU$112.5m
CAGR 3-Years
72%
CAGR 5-Years
85%
CAGR 10-Years
46%
Probiotec Ltd
ASX:PBP
Total Liabilities & Equity
AU$231.4m
CAGR 3-Years
10%
CAGR 5-Years
15%
CAGR 10-Years
8%
Vita Life Sciences Ltd
ASX:VLS
Total Liabilities & Equity
AU$68m
CAGR 3-Years
19%
CAGR 5-Years
15%
CAGR 10-Years
11%

See Also

What is Arovella Therapeutics Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
13.3m AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's Total Liabilities & Equity amounts to 13.3m AUD.

What is Arovella Therapeutics Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-4%

Over the last year, the Total Liabilities & Equity growth was 143%. The average annual Total Liabilities & Equity growth rates for Arovella Therapeutics Ltd have been 8% over the past three years , -4% over the past five years .

Back to Top